The HCl form is preferred for most industrial and pharmaceutical applications due to its superior shelf-life and solubility
Common side effects may include: Rare but more serious risks include: Our providers carefully evaluate each patients medical history and monitor progress closely to minimize risks
Common side effects may include: Nausea Diarrhea Vomiting Constipation Abdominal pain Indigestion Injection-site reactions Feeling tired Belching Hair loss Heartburn Rare, but serious side effects may include: Acute pancreatitis (including fatal, hemorrhagic, necrotizing) Acute gallbladder disease Acute kidney injury (typically secondary to dehydration) Severe gastrointestinal disease / delayed gastric emptying Hypoglycemia (especially with insulin or sulfonylureas) Hypersensitivity reactions including anaphylaxis and angioedema Pulmonary aspiration during anesthesia or deep sedation (delayed gastric emptying) Suicidal behavior and ideation (monitor) Diabetic retinopathy complications (in T2D clients with pre-existing retinopathy) Thyroid C-cell tumors (rodent data)
In two 6-month studies in type 2 diabetes patients, 25% of patients who received Insulin Glargine, U-300 once daily were positive for AIA at least once during the study, including 42% who were positive at baseline and 20% of patients who developed ADA during the study
If you maintain a hectic lifestyle that results in poor nutrition or high-stress levels, you may benefit from a boost to sustain your energy
